DOI: 10.1128/JVI.01620-20
Article Information
PubMed
Published By
History
- Received August 11, 2020
- Accepted December 3, 2020
- Published online February 10, 2021.
Copyright & Usage
Copyright © 2021 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Guido Silvestri, Editor, Emory University
Article Versions
- Accepted Manuscript version (December 09, 2020).
- You are viewing the most recent version of this article.
Author Information
- Dani Vézinaa,b,
- Shang Yu Gonga,c,
- William D. Tolbertd,
- Shilei Dinga,
- Dung Nguyend,
- Jonathan Richarda,b,
- Gabrielle Gendron-Lepagea,
- Bruno Melilloe,
- Amos B. Smith IIIe,
- Marzena Pazgierd and
- Andrés Finzia,b,c
- aCentre de Recherche du CHUM, Montreal, Quebec, Canada
- bDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada
- cDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada
- dInfectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
- eDepartment of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- Address correspondence to Andrés Finzi, andres.finzi{at}umontreal.ca.
Citation Vézina D, Gong SY, Tolbert WD, Ding S, Nguyen D, Richard J, Gendron-Lepage G, Melillo B, Smith AB, III, Pazgier M, Finzi A. 2021. Stabilizing the HIV-1 envelope glycoprotein State 2A conformation. J Virol 95:e01620-20. https://doi.org/10.1128/JVI.01620-20.
